Pictet Asset Management (Switzerland)’s Intellia Therapeutics NTLA Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio NTLA Stock Details NTLA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$42.6M	Buy
2023 Q1	$35.1M	Buy
2022 Q4	$27.3M	Buy
2022 Q3	$42.9M	Buy
2022 Q2	$32.9M	Buy
2022 Q1	$26.6M	Sell
2021 Q4	$49.9M	Buy
2021 Q3	$34.2M	Buy